Interview with Pluristem President and CEO Yaky Yanay

Benzinga

•

February 24th, 2022

DESCRIPTION

Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, hematological disorders and exposure to radiation $PSTI

Benzinga

Benzinga delivers fast, actionable financial news and market insights to help investors stay ahead of the curve. From breaking market headlines and earnings coverage to expert analysis on stocks, options, futures, crypto, and macro trends, Benzinga connects audiences with the information that moves markets. Our video content features real-time market commentary, educational segments, and exclusive interviews with industry leaders—designed for active traders, long-term investors, and anyone looking to better understand the financial landscape.